MiNK Therapeutics, Inc. - Common Stock

MiNK Therapeutics, Inc. - Common Stock

Share · US6036931029 · INKT (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MiNK Therapeutics, Inc. - Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
1
0
0
No Price
29.04.2026 08:00
Current Prices from MiNK Therapeutics, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
INKT
USD
29.04.2026 08:00
11,10 USD
0,22 USD
+2,02 %
IEXG: IEX
IEX
INKT
USD
28.04.2026 19:58
10,85 USD
-0,29 USD
-2,60 %
Share Float & Liquidity
Free Float 23,97 %
Shares Float 1,19 M
Shares Outstanding 4,97 M
Company Profile for MiNK Therapeutics, Inc. - Common Stock Share
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.

Company Data

Name MiNK Therapeutics, Inc. - Common Stock
Company MiNK Therapeutics, Inc.
Symbol INKT
Website https://minktherapeutics.com
Primary Exchange XNAS NASDAQ
ISIN US6036931029
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jennifer S. Buell
Market Capitalization 58 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 149 Fifth Avenue, 10010 New York City
IPO Date 2021-10-15

Stock Splits

Date Split
28.01.2025 1:10

Ticker Symbols

Name Symbol
Frankfurt 6Q4.F
NASDAQ INKT
More Shares
Investors who hold MiNK Therapeutics, Inc. - Common Stock also have the following shares in their portfolio:
NATIONAL GRID ELECTRICITY TRANSMISSION PLC 3.35% INTS 27/09/32
NATIONAL GRID ELECTRICITY TRANSMISSION PLC 3.35% INTS 27/09/32 Bond
ROTHESAY LFE 21/UND. FLR
ROTHESAY LFE 21/UND. FLR Bond